Dr. Kiara L. Moore, Clinical Trials, FDA Corey Hubbard Dr. Kiara L. Moore, Clinical Trials, FDA Corey Hubbard

CT-155 Shakes Up Schizophrenia Treatment: A Digital Revolution Begins

Schizophrenia, a complex and challenging neuropsychiatric disorder, has historically presented significant hurdles in treatment, particularly concerning its "negative symptoms". For too long, patients have grappled with therapies that primarily address the more visible psychotic symptoms like hallucinations, often leaving critical aspects of their well-being unaddressed

Read More